William Heyburn Sells 31,671 Shares of Strata Critical Medical (NASDAQ:SRTA) Stock

Strata Critical Medical (NASDAQ:SRTA) CEO William Heyburn sold 31,671 shares of the firm’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $185,908.77. Following the completion of the sale, the chief executive officer directly owned 1,548,997 shares of the company’s stock, valued at approximately $9,092,612.39. This represents a 2.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Strata Critical Medical Stock Performance

NASDAQ:SRTA opened at $5.49 on Friday. The stock has a 50-day moving average of $5.19. Strata Critical Medical has a 12 month low of $3.57 and a 12 month high of $6.50. The stock has a market cap of $475.03 million, a PE ratio of -68.63 and a beta of 2.20.

Strata Critical Medical (NASDAQ:SRTA) last posted its earnings results on Wednesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.07. Strata Critical Medical had a negative return on equity of 4.06% and a net margin of 20.56%.The firm had revenue of $67.38 million for the quarter. On average, equities research analysts expect that Strata Critical Medical will post -0.14 earnings per share for the current fiscal year.

Institutional Trading of Strata Critical Medical

A number of hedge funds have recently made changes to their positions in SRTA. Seelaus Asset Management LLC boosted its position in shares of Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after purchasing an additional 6,000 shares in the last quarter. Granite Investment Partners LLC boosted its position in shares of Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after purchasing an additional 7,911 shares in the last quarter. Principal Financial Group Inc. bought a new stake in shares of Strata Critical Medical in the 1st quarter worth approximately $537,000. Dimensional Fund Advisors LP boosted its position in shares of Strata Critical Medical by 11.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock worth $6,759,000 after purchasing an additional 172,154 shares in the last quarter. Finally, Quantinno Capital Management LP boosted its position in shares of Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after purchasing an additional 71,155 shares in the last quarter. 47.36% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

SRTA has been the topic of a number of research analyst reports. Craig Hallum initiated coverage on Strata Critical Medical in a report on Wednesday, March 25th. They set a “buy” rating and a $8.00 target price on the stock. B. Riley Financial initiated coverage on Strata Critical Medical in a report on Wednesday, March 25th. They set a “buy” rating and a $8.00 target price on the stock. Zacks Research upgraded Strata Critical Medical to a “hold” rating in a report on Thursday, March 26th. Finally, Weiss Ratings upgraded Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Strata Critical Medical currently has an average rating of “Moderate Buy” and an average price target of $8.00.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.